Saxagliptin not linked to increased fracture risk in T2DM
(HealthDay)—For patients with type 2 diabetes, treatment with saxagliptin is not associated with increased fracture risk, according to a study published online Sept. 10 in Diabetes Care.
Sep 25, 2015
0
4